Hepatic safety and tolerability of cipargamin (KAE609), in adult patients with Plasmodium falciparum malaria: a randomized, phase II, controlled, dose-escalation trial in sub-Saharan Africa

DSpace Repository

Hepatic safety and tolerability of cipargamin (KAE609), in adult patients with Plasmodium falciparum malaria: a randomized, phase II, controlled, dose-escalation trial in sub-Saharan Africa

Author: Ndayisaba, Gilles; Yeka, Adoke; Asante, Kwaku Poku; Grobusch, Martin P.; Karita, Etienne; Mugerwa, Henry; Asiimwe, Stephen; Oduro, Abraham; Fofana, Bakary; Doumbia, Seydou; Jain, Jay Prakash; Barsainya, Sarita; Kullak-Ublick, Gerd A.; Su, Guoqin; Schmitt, Esther K.; Csermak, Katalin; Gandhi, Preetam; Hughes, David
Tübinger Autor(en):
Grobusch, Martin
Published in: Malaria Journal (2021), Bd. 20, H. 1
Verlagsangabe: London
Language: English
Full text: http://dx.doi.org/10.1186/s12936-021-04009-1
ISSN: 1475-2875
DDC Classifikation: 610 - Medicine and health
570 - Life sciences; biology
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)